In the routine implementation, various histopathological receptors including estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki67 are widely used to determine the clinical subtypes of BC, and guide the clinical decision-making [6,7]. Here, ESR1 is linked to breast cancer.